ASCO 2026 | Management of brain metastasis in patients with poor-risk testicular cancer

Darren Feldman • 30 May 2026

ASCO 2026

Darren Feldman, MD, Memorial Sloan Kettering Cancer Center, New York, NY, shares insights into how clinicians should manage brain metastasis in patients with poor-risk testicular cancer. Dr Feldman describes the typical presentation of patients with brain metastasis, including extensive lung metastases, very high hCG levels and choriocarcinoma histology, and highlights their high-risk of bleeding, necessitating frequent imaging and multidisciplinary care. This interview took place during the 2026 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.